Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Onglyza
Pharma
AstraZeneca steps up its Farxiga game with CV outcomes win
With data showing Farxiga can reduce hospitalizations for heart failure or CV deaths against placebo, AZ plans to seek a label update.
Eric Sagonowsky
Sep 24, 2018 11:55am
ADA: AZ exec 'very optimistic' about Farxiga outcomes study
Jun 27, 2018 11:37am
BMS, AZ in legal hot seat over Onglyza heart failure warning
May 8, 2017 11:31am
AZ bounces back with diabetes combo win
Feb 28, 2017 11:33am
AZ's FDA-rejected diabetes combo grabs first-to-market status in Europe
Jul 20, 2016 8:39am
AstraZeneca puts top brands on one-size-fits all mobile app
Jun 19, 2016 11:34am
